(±)-Cp-96,345, a Selective Tachykinin NK1 Receptor Antagonist, Has Non-Specific Actions on Neurotransmission

British Journal of Pharmacology - United States
doi 10.1111/j.1476-5381.1992.tb14520.x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Effects of CP-96,345, a Novel Non-Peptide Antagonist of NK1 Receptor, on the Peristalsis in Isolated Guinea Pig Ileum.

The Japanese Journal of Pharmacology
1992English

The Broad-Spectrum Anti-Emetic Activity of the Novel Non-Peptide Tachykinin NK1 Receptor Antagonist GR203040

British Journal of Pharmacology
Pharmacology
1995English

Effect of TAK-637, a Tachykinin NK1-Receptor Antagonist, on Lower Urinary Tract Function in Cats.

The Japanese Journal of Pharmacology
2001English

Tachykinin Precursor 1 (TAC1; NK1; NK2); Tachykinin Receptor 1 (TACR1; NK1R)

Science-Business eXchange
2009English

Block of Voltage-Dependent Sodium Currents by the Substance P Receptor Antagonist (±)-Cp-96,345 in Neurones Cultured From Rat Cortex

British Journal of Pharmacology
Pharmacology
1993English

KD-64 – A New Selective A2A Adenosine Receptor Antagonist Has Anti-Inflammatory Activity but Contrary to the Non-Selective Antagonist – Caffeine Does Not Reduce Diet-Induced Obesity in Mice

2020English

CP-465,022, a Selective Noncompetitive AMPA Receptor Antagonist, Blocks AMPA Receptors but Is Not Neuroprotective in Vivo

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2003English

Attenuation of Ischemic Liver Injury by a Non-Selective Endothelin Receptor Antagonist

Transplantation Proceedings
SurgeryTransplantation
1997English

Two Active Molecular Phenotypes of the Tachykinin NK1 Receptor Revealed by G-Protein Fusions and Mutagenesis

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy